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DNAX accessory molecule-1 (DNAM-1), also known as 
CD226, is a receptor expressed on natural killer (NK) cells, 
CD8+ T cells, some CD4+ T cells, and some myeloid cells 
(Shibuya et al., 1996; Long et al., 2013; de Andrade et al., 
2014; Martinet and Smyth, 2015). Although it is part of the 
Ig superfamily, DNAM-1 is rather unique. This uniqueness is 
especially evident in the cytoplasmic domain, which shares 
little or no homology with other Ig superfamily members. 
DNAM-1 recognizes CD155 (poliovirus receptor) and 
CD112 (nectin-2) as ligands, which are expressed on a broad 
range of cells, including transformed cells and virus-infected 
cells (Bottino et al., 2003). CD155, CD112, or both are also 
ligands for the inhibitory receptors TIG IT and CD96 (tac-
tile), which are also expressed on immune cells. As loss of 
DNAM-1 enhances the availability of CD155 and CD112 
for TIG IT and CD96, this feature complicates interpretation 
of phenotypes found in mice lacking DNAM-1.
DNAM-1 was initially identified as a molecule pro-
moting cytotoxicity and cytokine secretion by NK cells and 
CD8+ T cells (Shibuya et al., 1996). Subsequent work re-
vealed that DNAM-1 was important for NK cell–mediated 
killing of tumor cells such as melanoma cells, rhabdomyosar-
coma cells, and Ewing’s sarcoma cells (Verhoeven et al., 2008; 
Lakshmikanth et al., 2009; Cho et al., 2010). Accordingly, 
DNAM-1–deficient mice were more susceptible to carcin-
ogen-induced fibrosarcoma and papilloma in vivo (Gilfillan 
et al., 2008; Iguchi-Manaka et al., 2008). DNAM-1 was also 
implicated in NK cell–mediated elimination of HIV-infected 
CD4+ T cells and human cytomegalovirus (HCMV)-infected 
DCs (Magri et al., 2011; Matusali et al., 2012). Moreover, in 
mice, it played a critical role in expansion and survival of 
virus-specific memory NK cells in mouse cytomegalovirus 
(MCMV)–infected mice (Nabekura et al., 2014). A key role of 
DNAM-1 was also documented in CD8+ T cells. DNAM-1 
was critical for the ability of CD8+ T cells to eliminate tumor 
cells and virus-infected cells during blocking antibody ther-
apy targeting the inhibitory receptor TIG IT (Johnston et al., 
2014). Likewise, DNAM-1 was necessary for the ability of 
CD8+ T cells to mediate acute graft-versus-host disease in 
mice (Nabekura et al., 2010).
Early studies suggested that human DNAM-1 promotes 
NK cell activation, at least in part, by acting as an adhesion 
receptor, which stabilizes physical contacts between NK cells 
and target cells (Shibuya et al., 1996, 1999). This function was 
reportedly dependent on the ability of DNAM-1 to bind in 
cis to integrin LFA-1. DNAM-1 was also shown to undergo 
phosphorylation at a conserved tyrosine (Y) in its cytoplas-
mic domain (Y319 in mouse and Y322 in human; Shibuya et 
al., 1999). This phosphorylation was reported to be mediated 
by Src family kinase Fyn. Although the precise role of Y319 
was not elucidated (for simplification, mouse numbering will 
be used in this report), the ability of DNAM-1 to stimu-
late accumulation of virus-induced memory-like NK cells in 
mice was dependent on Y319 (Nabekura et al., 2014). Human 
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DNAM-1 was also described to undergo phosphorylation at 
serine 326 (S326) in its cytoplasmic domain, as a result of the 
action of protein kinase C (Shibuya et al., 1998, 1999). This 
phosphorylation was reported to promote the DNAM-1–
LFA-1 association and, in mice, to be critical for accumulation 
of memory-like NK cells in virus-infected mice (Shibuya et 
al., 1999; Nabekura et al., 2014).
Various reports have examined the possibility that 
DNAM-1 transduces intrinsic biochemical signals. In some 
studies, engagement of human DNAM-1 by anti–DNAM-1 
antibodies failed to trigger activation of kinases Erk and Akt 
or calcium fluxes (Bryceson et al., 2006; Chen et al., 2007). 
In other studies, human DNAM-1 synergized with 2B4 to 
enhance tyrosine phosphorylation of adaptor SLP-76 and ex-
change factor Vav-1 (Kim and Long, 2012). This effect cor-
related with increased NK cell–mediated cytotoxicity and 
cytokine production. However, the mechanism by which 
DNAM-1 influenced these signals was not determined.
Whether DNAM-1 functions as an adhesion receptor, a 
signal transduction molecule or both during NK cell activa-
tion needs to be resolved. The structural basis for the ability of 
DNAM-1 to mediate possible signals, as well as the effectors 
of these signals, also requires clarification. Lastly, the cellular 
mechanism by which DNAM-1 promotes NK cell activa-
tion, i.e., enhanced cellular adhesion or other mechanisms, 
requires clarification.
Herein, we addressed these issues using a combination 
of genetic, biochemical, molecular, and imaging approaches. 
These studies showed that engagement of DNAM-1 triggered 
active signals, which were required for the ability to promote 
NK cell activation. These signals were initiated by Y319, but 
not S326, of DNAM-1. They also necessitated an asparagine 
at position 321 (N321), which cooperated with phosphor-
ylated Y319 to bind adaptor Grb2. Binding of DNAM-1 to 
Grb2 enabled activation of exchange factor Vav-1, phospha-
tidylinositol (PI) 3′ kinase, and phospholipase C (PLC)-γ1. 
DNAM-1 signaling did not enhance cytotoxicity by promot-
ing adhesion. Rather, it acted by enhancing actin polymer-
ization and polarization of lytic granules toward target cells.
RES ULTS
DNAM-1 triggers signals involving activation of Erk, 
Akt, and calcium fluxes
To resolve the mechanism by which DNAM-1 promotes NK 
cell activation, the ability of DNAM-1 to trigger intracellular 
signals in the absence of engagement of other activating recep-
tors was examined (Fig. 1). Stimulation of normal mouse NK 
cells with anti–DNAM-1 antibodies (anti–DNAM-1) resulted 
in activation of kinases Erk and Akt (Fig. 1 A). This was not a 
result of triggering of CD16, an activating Fc receptor on NK 
cells, as these effects were lost in NK cells from DNAM-1–defi-
cient mice (Fig. 1 B). We also examined the ability of DNAM-1 
to trigger calcium fluxes (Fig.  1, C and D). Normal mouse 
NK cells contained both DNAM-1+ and DNAM-1− subsets, 
as previously reported (Tahara-Hanaoka et al., 2005; Fig. 1 C). 
Stimulation with anti–DNAM-1 induced calcium fluxes in 
DNAM-1+, but not in DNAM-1−, NK cells (Fig. 1 D).
Mouse DNAM-1 was also ectopically expressed in the 
human NK cell line YT-S, which lacks CD16 (Fig. 1, E and 
H; and not depicted). Triggering of mouse DNAM-1 on 
YT-S cells resulted in activation of Erk and Akt (Fig. 1, E and 
F). Additionally, it triggered calcium fluxes (Fig.  1 G). Im-
portantly, expression of mouse DNAM-1 on YT-S also en-
abled killing of B16, a mouse melanoma cell line expressing 
ligands for DNAM-1 (Dong et al., 2009), as well as RMA-S 
mouse lymphoma cells ectopically expressing mouse CD155 
(Fig. 1, E and H). No killing was seen toward RMA-S cells 
lacking CD155, or when YT-S cells lacked mouse DNAM-1. 
Consequently, in this experimental system, engagement of 
DNAM-1 was strictly needed for target cell killing.
These data showed that engagement of DNAM-1 on 
NK cells triggered active biochemical signals involving acti-
vation of Erk, Akt, and calcium fluxes. These signals correlated 
with enhanced natural cytotoxicity.
Y319, but not S326, is critical for DNAM-1–mediated 
signaling and cytotoxicity
To determine the mechanism by which DNAM-1 coupled 
to these signals, we focused on the cytoplasmic domain. Al-
though the sequence in this region is quite divergent across 
species, there is a stretch of 5 aa, D/EIYV/MN (where D is as-
partic acid, E is glutamic acid, V is valine, M is methionine, and 
N is asparagine), that is highly conserved in all species, includ-
ing mouse and human (Fig. 2 A). This sequence encompasses 
the aforementioned site of phosphorylation, Y319 (Shibuya et 
al., 1999). The other proposed phosphorylation site, S326, is 
located outside of this motif (Shibuya et al., 1998). Moreover, 
S326 is present in mouse and human, but not in other species.
To examine if these phosphorylation sites were critical for 
the ability of DNAM-1 to trigger signals and promote cytotoxic-
ity, mutants of mouse DNAM-1 carrying a tyrosine 319-to-phe-
nylalanine 319 (Y319F) or a serine 326-to-alanine 326 (S326A) 
mutation, two conserved substitutions aimed at preventing 
phosphorylation without affecting structure, were introduced in 
YT-S cells. Both mutants were expressed in amounts analogous 
to those of WT DNAM-1 (Fig. 2 B). The Y319F mutation fully 
abrogated the capacity of DNAM-1 to trigger activation of Erk 
and Akt (Fig. 2 C). In contrast, the S326A substitution had no 
effect. Likewise, Y319F, but not S326A, eliminated the capacity of 
DNAM-1 to mediate cytotoxicity toward B16 cells or RMA-S 
cells expressing CD155 (Fig. 2 D).
Hence, the highly conserved Y319, but not the less con-
served S326, was needed for the ability of DNAM-1 to stim-
ulate intracellular signals and cytotoxicity in YT-S cells.
Generation and analyses of DNAM-1 
Y319F knock-in (KI) mouse
To establish the physiological relevance of this mechanism, a 
KI mouse, in which Y319 was changed to phenylalanine in 
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construct depicted in Fig. 3 A was used to introduce the mu-
tation in embryonic stem (ES) cells from C57BL/6 mice. After 
germline transmission of the mutation, breeding of mutant 
mice with animals expressing the Flpe recombinase eliminated 
the neo selection cassette. As reported for DNAM-1–defi-
cient mice (Gilfillan et al., 2008; Iguchi-Manaka et al., 2008), 
DNAM-1 Y319F mice exhibited no alterations of NK cell 
numbers, development, or repertoire (Fig. 3, B and C). These 
mice also displayed unaltered levels of DNAM-1 on NK cells. 
The proportion of DNAM-1+ NK cells was also not affected.
Figure 1. Impact of engagement of DNAM-1 on activation of Erk, Akt, and calcium fluxes in NK cells. (A) IL-2–activated NK cells from WT mice 
were stimulated for 2 min with anti–mouse DNAM-1 (480.2), followed by secondary antibodies (+) or secondary antibodies alone (-). Activation of Erk 
and Akt was assessed by immunoblotting with antibodies against phosphorylated Erk (α-pErk) or Akt (α-pAkt). Quantitation of relative phosphorylation is 
shown at the bottom. Representative of at least n = 3. (B) Same as A, except that WT and DNAM-1–deficient (KO) mice were analyzed. Representative of at 
least n = 3. (C) Expression of DNAM-1 on splenic NK cells (defined as NK1.1+CD3− cells) was analyzed by flow cytometry. Isotype control is shown as filled 
histograms. Percentage of DNAM-1+ NK cells is indicated. Representative of at least n = 5. (D) IL-2–activated NK cells were labeled with FITC-conjugated 
anti–mouse DNAM-1 and loaded with Indo-1, followed by secondary antibodies (stimulated) or not (unstimulated). The changes of intracellular calcium 
(monitored as FL4/FL5 ratio) in DNAM-1+ (top) and DNAM-1− (middle) NK cells were analyzed. Cells were treated with ionomycin (bottom) as positive con-
trol. Arrow indicates when the secondary antibodies or ionomycin was added. Representative of n = 5. (E) Expression of mouse DNAM-1 (top) and mouse 
CD155 (bottom) on transfected or retrovirus-transduced YT-S cells and RMA-S cells, respectively, was determined by flow cytometry. Cells expressing the 
puromycin resistance marker (puro) or GFP alone were used as control. Isotype control is shown as filled histogram. Representative of at least n = 3. (F) YT-S 
cells expressing mouse DNAM-1 (mDNAM-1) or puromycin-resistant marker (puro) alone were stimulated with anti–DNAM-1, and activation of Erk and Akt 
was assessed, as detailed for A. Representative of n = 5. (G) YT-S cells expressing mouse DNAM-1 (mDNAM-1) or puromycin-resistant marker (puro) alone 
were loaded with Indo-1. They were then stimulated with anti–mouse DNAM-1, followed by secondary antibodies (stimulated), or secondary antibodies 
alone (unstimulated). Changes of intracellular calcium were monitored as FL4/FL5 ratio. Arrow indicates when the secondary antibodies or ionomycin was 
added. Representative of n = 3. (H) Natural cytotoxicity of YT-S cells expressing mouse DNAM-1 (mDNAM-1) or puromycin resistant marker (puro) alone 
was tested in a 51Cr-release assay at indicated effector-to-target (E/T) ratio. The target cells used were B16 or RMA-S expressing or not expressing mouse 
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As was the case for NK cells lacking DNAM-1, NK cells 
expressing DNAM-1 Y319F displayed compromised activa-
tion of Erk and Akt in response to anti–DNAM-1 (Fig. 3 D). 
A markedly reduced ability to evoke calcium fluxes was also 
observed (Fig.  3  E). Furthermore, like DNAM-1–deficient 
NK cells, NK cells expressing DNAM-1 Y319F showed a re-
duced ability to kill the nonhematopoietic target cells B16 
and Neuro-2a (neuroblastoma), which express ligands for 
DNAM-1, but not for NKG2D (Dong et al., 2009; Fig. 4, A 
and B). A defect was also seen toward CMT-93 (rectal carci-
noma), which expresses ligands for DNAM-1 and NKG2D. 
Notably, with these three targets, the defects observed with 
DNAM-1 Y319F NK cells were slightly less severe than those 
noted with DNAM-1–deficient NK cells. The possible sig-
nificance of this finding will be discussed below. No defect 
was seen in cytotoxicity toward RMA-S or YAC-1, either 
with DNAM-1–deficient or with DNAM-1 Y319F NK cells.
We also tested the impact of the Y319F mutation on 
production of IFN-γ (Fig. 4 C). Splenic NK cells were in-
cubated or not with B16, and IFN-γ production was de-
termined by intracellular staining. As was the case of lack 
of DNAM-1, mutation of Y319F abrogated the ability of 
DNAM-1 to promote IFN-γ production in response to B16. 
No difference was seen when cells were activated with phor-
bol myristate acetate (PMA) and ionomycin, which trigger 
cytokine production by bypassing activating receptors. Be-
cause only ∼50% of mouse NK cells express DNAM-1, we 
also compared production of IFN-γ by DNAM-1+ NK cells 
from WT or DNAM-1 KI mice (Fig. 4 D). Compared with 
WT NK cells, DNAM-1 KI NK cells displayed a markedly 
attenuated IFN-γ production in the presence of B16.
Thus, as was the case in YT-S cells, mutation of Y319 
severely attenuated the ability of DNAM-1 to mediate sig-
nals, as well as to promote cytotoxicity and cytokine pro-
duction in mouse NK cells.
DNAM-1 promotes cytotoxicity via a tyrosine- and 
asparagine-based motif that couples to Grb2
We postulated that, when phosphorylated, Y319 was cou-
pling DNAM-1 to a specific set of intracellular signaling 
molecules promoting NK cell activation. To identify these 
effectors, we opted to use primarily the YT-S system, for 
the following reasons. First, it was easier to generate large 
numbers of YT-S cells for biochemical studies. Second, 
our derivatives of YT-S cells uniformly expressed mouse 
DNAM-1, whereas only ∼50% of mouse NK cells ex-
pressed DNAM-1 and this fraction was further diminished 
when NK cells were expanded in IL-2 (unpublished data). 
Third, stimulation of mouse DNAM-1 on YT-S cells gener-
ated signals (activation of Erk, Akt, and calcium fluxes) anal-
ogous to those seen in normal mouse NK cells. Moreover, 
in both systems, these signals were dependent on Y319. And 
fourth, YT-S cells were ideal for structure–function analyses 
of DNAM-1, as expression of mouse DNAM-1 in these 
Figure 2. Y319, but not S326, is required for DNAM-1–dependent natural cytotoxicity. (A) Alignment of the C-terminal sequence of DNAM-1 from 
various species. Amino acids that are strictly conserved are highlighted in dark gray. Partially conserved residues are shown in lighter gray. The positions of 
tyrosine 319 (Y319) and serine 326 (S326) in the mouse sequence (indicated by asterisks) are shown. (B) Expression of DNAM-1 on YT-S cells transfected 
with cDNAs encoding WT mouse DNAM-1 or mouse DNAM-1 mutants carrying a tyrosine 319-to-phenylalanine 319 (Y319F) or serine 326-to-alanine 
326 (S326A) substitution was determined by flow cytometry. Cells expressing the puromycin resistant marker (puro) alone are included as control. Isotype 
controls are shown as filled histograms. Representative of n = 4. (C) The YT-S cells described in B were stimulated with anti–DNAM-1 and activation of 
Erk and Akt was assessed, as detailed for Fig. 1 F. Quantitation of relative phosphorylation is shown at the bottom. Representative of n = 3. (D) The YT-S 
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cells was absolutely required for killing of mouse target cells 
expressing DNAM-1 ligands.
To identify effectors that directly interacted with 
DNAM-1, peptides corresponding to aa 315–333 in the 
cytoplasmic domain of mouse DNAM-1 were synthesized, 
phosphorylated or not at Y319 (Fig.  5 A). After immobi-
lization onto agarose beads, peptides were used to capture 
binding proteins from lysates of YT-S cells (Fig. 5 B). Bound 
proteins were identified by silver staining of protein gels. A 
single polypeptide of ∼25 kD (p25) was bound to the peptide 
Figure 3. Generation and signaling analyses of mice expressing DNAM-1 Y319F. (A) The genomic structure of the DNAM-1–encoding gene in the 
mouse, Cd226, is shown at the top. Tyrosine 319 (Y319) is encoded by exon 7, which also contains the stop codon. The targeting construct is shown in 
the middle. In this construct, the WT codon for Y319, TAT, was replaced by a codon for phenylalanine, TTT. The final Y319F knock-in (KI) Cd226 allele carrying 
the mutated codon is shown at the bottom. (B) Splenocytes from WT, DNAM-1–deficient (KO), or DNAM-1 Y319F (KI) mice were analyzed by flow cytometry. 
Proportions of NK cells (NK1.1+CD3− cells) are indicated (left). Expression of CD11b, CD27, and DNAM-1 on NK cells was also analyzed (middle and right). 
Percentages of NK cells in each quadrant (middle), as well as of DNAM-1+ NK cells (right), are shown. Isotype controls are depicted as filled histogram. 
Representative of n = 4. (C) Expression of various receptors was analyzed on NK1.1+CD3− splenocytes from WT, KI, or KO mice, using flow cytometry. Isotype 
controls are shown as the red line. Representative of n = 2. (D) Same as Fig. 1 A, except that WT, DNAM-1 KO, and DNAM-1 KI NK cells were analyzed. Quan-
titation of relative phosphorylation is shown at the bottom. Representative of n = 3. (E) Same as Fig. 1 D, except that only DNAM-1+ NK cells were analyzed. 
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phosphorylated at Y319, but not to the unphosphorylated 
peptide. Mass spectrometry revealed that p25 was Grb2, an 
intracellular adaptor composed of one Src homology 2 (SH2) 
domain flanked by two Src homology 3 (SH3) domains 
(Lowenstein et al., 1992; Pawson and Scott, 1997). The ability 
of the phosphorylated DNAM-1 peptide to bind Grb2 was 
confirmed by immunoblotting of peptide-associated proteins 
with anti-Grb2 antibodies (Fig. 5 C).
Phosphorylated Y319 (pY319) is nested in the sequence 
pYVNY, which is compatible with the consensus binding 
motif for the SH2 domain of Grb2, pYxNx (where x is any 
residue; Songyang et al., 1994). Accordingly, the phosphory-
Figure 4. Cytotoxicity and cytokine production by DNAM-1 Y319F mouse NK cells. (A) Natural cytotoxicity of NK cells from WT, DNAM-1 KO, or 
DNAM-1 KI mice was tested in a 51Cr-release assay, using as targets B16, Neuro-2a, CMT-93, RMA-S, or YAC-1. SDs of duplicate values are depicted by error 
bars. Representative of n = 5. (B) Expression of ligands for DNAM-1 and NKG2D on target cells. Expression of the DNAM-1 ligands, CD155 and CD112, and 
NKG2D ligands (detected using an NKG2D-Fc fusion protein) was assessed by flow cytometry. Isotype controls are shown as the red line. Representative 
of n = 3. (C and D) Splenocytes from poly(I:C)-primed mice were incubated with B16 for 6 h. Production of IFN-γ in total NK cells (NK1.1+CD3−; C) or 
DNAM-1+ NK cells (NK1.1+CD3−DNAM-1+; D) was analyzed by intracellular staining. Splenocytes without any target or splenocytes stimulated with phorbol 
myristate acetate and ionomycin (PMA/iono) served as controls. Representative dot plots are shown in C (left). Average values with SDs of triplicates from 
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Figure 5. DNAM-1 promotes NK cell activation via a tyrosine- and asparagine-based motif that recruits Grb2. (A) Biotinylated peptides correspond-
ing to the carboxyl-terminus of mouse DNAM-1 were synthesized, with (pY319) or without (Y319) phosphorylation at tyrosine 319. In some peptides, additional 
mutations were introduced: N321Q, in which asparagine 321 was mutated to glutamine and Y322F, in which tyrosine 322 was mutated to phenylalanine. The 
mutated residues are indicated by arrows. (B) DNAM-1 peptides were coupled to agarose beads and used to capture binding proteins from lysates of YT-S cells. 
Bound proteins were identified by silver staining of protein gels. Agarose beads alone (no pep) served as control. The migration of molecular mass markers is in-
dicated on the left. Representative of n = 4. (C) DNAM-1 peptides were incubated with lysates of YT-S cells and bound proteins were probed by immunoblotting 
with anti-Grb2 antibodies. Representative of n = 4. (D) DNAM-1 peptides were incubated with lysates of bacteria expressing the indicated glutathione-S-trans-
ferase (GST) fusion proteins. Nonpurified GST-Grb2 SH2 fusion proteins served as control. Representative of n = 2. (E and F) YT-S cells were transfected with 
cDNAs encoding WT, Y319F, N321Q, or Y322F mouse DNAM-1, or the puromycin resistant marker (puro) alone. Expression of mouse DNAM-1 was tested 
by flow cytometry. Isotype controls are shown as filled histogram (E). Representative of n = 4. They were then stimulated (+) or not (−) with anti–DNAM-1 
antibodies and the relevant secondary antibody (F). The association of DNAM-1 with Grb2 was detected by immunoblotting of DNAM-1 immunoprecipitates 
with anti-Grb2 antibodies. Migration of heavy chain of IgG is shown on the left. Representative of n = 3. (G) The YT-S cells described in Fig. 5 E were tested for 
natural cytotoxicity, as detailed for Fig. 1 H. SDs of duplicate values are depicted by error bars. Representative of n = 3. (H and I) YT-S cells expressing WT mouse 
DNAM-1 were transfected with Grb2-specific siRNAs (siGrb2 #1) or irrelevant siRNAs (siCtr) as control. Down-regulation of Grb2 expression was assessed by 
immunoblotting with anti-Grb2 (H). Cells were also tested for natural cytotoxicity, as detailed for Fig. 1 H (I). SDs of duplicate values are depicted by error bars. 
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lated DNAM-1 peptide bound to recombinant Grb2 SH2 
domains in vitro (Fig.  5  D). Moreover, the association be-
tween the phosphorylated DNAM-1 peptide was eliminated 
when the highly conserved asparagine at the +2 position was 
mutated to glutamine (N321Q mutation; Fig. 5, C and D). 
However, it was not affected when the less conserved residue 
at +3 position (Y322) was altered (Y322F mutation).
To show that DNAM-1 associated with Grb2 via the 
pYxNx motif in cells, YT-S cells expressing WT, Y319F, N321Q, 
or Y322F DNAM-1 were created and stimulated with anti–
DNAM-1 (Fig. 5, E and F). The association of DNAM-1 with 
Grb2 was detected by immunoblotting of anti–DNAM-1 im-
munoprecipitates with anti-Grb2 (Fig.  5  F). WT DNAM-1 
coimmunoprecipitated with Grb2 in cells stimulated with anti–
DNAM-1 antibodies. Minimal association was seen in unstim-
ulated cells. As shown in the aforementioned in vitro binding 
assays, this association was abolished by the Y319F or N321Q, 
but not the Y322F, mutation. All mutants were expressed in 
amounts analogous to those of WT DNAM-1 (Fig. 5 E).
To ascertain if Grb2 binding was critical for the acti-
vating function of DNAM-1, we first tested the ability of 
these various DNAM-1 mutants to promote cytotoxicity 
(Fig. 5 G). As was the case for mutation of Y319, the N321Q 
mutation eliminated the ability of DNAM-1 to enhance 
cytotoxicity toward B16, Neuro-2a, and CD155-expressing 
RMA-S. In contrast, the Y322F mutation had no effect.
Next, we ascertained the impact of reduced Grb2 expres-
sion on DNAM-1 function. Unfortunately, these experiments 
could not be performed with NK cells from Grb2-deficient 
mice, as lack of Grb2 interfered with proper NK cell develop-
ment in mice (unpublished data). Hence, we down-regulated 
expression of Grb2 in YT-S cells, using siRNAs (Fig.  5, H 
and I; and not depicted). Two different Grb2-specific siRNAs, 
but not control siRNAs, induced an ∼40–70% diminution of 
Grb2 expression in YT-S cells (Fig. 5 H; and not depicted). 
Importantly, they also caused a reduction of cytotoxicity to-
ward B16 and RMA-S cells expressing CD155 (Fig. 5 I; and 
not depicted). As the ability of YT-S cells to kill RMA-S cells 
expressing CD155 was strictly dependent on expression of 
DNAM-1 on YT-S cells (Fig. 1 H), the latter finding sup-
ported the notion that Grb2 was directly implicated in the 
activating function of DNAM-1.
Combined, these results showed that phosphoryla-
tion of the highly conserved tyrosine- and asparagine-based 
motif of DNAM-1 resulted in recruitment of Grb2, which 
was needed for the ability of DNAM-1 to promote NK 
cell–mediated cytotoxicity.
Grb2 couples DNAM-1 to Vav-1, PI3′K, and PLC-γ1
Next, we postulated that, whereas the SH2 domain of Grb2 
interacted with tyrosine-phosphorylated DNAM-1, one 
or both of its SH3 domains were involved in recruitment 
of downstream effectors. To identify these effectors, sev-
eral approaches were taken. First, DNAM-1 was immuno-
precipitated from YT-S cells expressing WT DNAM-1 or 
DNAM-1 Y319F, stimulated or not with anti–DNAM-1. 
DNAM-1–associated proteins were then detected by immu-
noblotting with antiphosphotyrosine antibodies (Fig.  6  A). 
Immunoprecipitates of WT DNAM-1 from stimulated cells 
contained tyrosine phosphorylated proteins of ∼45–50 kD 
(p45-50) and ∼95 kD (p95). Both products were less prom-
inently detectable in unstimulated cells and were absent in 
cells bearing DNAM-1 Y319F.
Whereas p45-50 was likely DNAM-1 itself, p95 was 
suggestive of Vav-1, an exchange factor known to associate 
with Grb2 SH3 domains (Ramos-Morales et al., 1994; Bus-
telo, 2001). To address if p95 was Vav-1, denatured eluates of 
DNAM-1 immunoprecipitates were reimmunoprecipitated 
with anti–Vav-1 antibodies. Tyrosine-phosphorylated proteins 
were then detected by antiphosphotyrosine immunoblotting 
(Fig.  6  B). Tyrosine-phosphorylated p95 was recovered by 
reimmunoprecipitation with anti–Vav-1 antibodies, but not 
with normal rabbit serum. This experiment confirmed that 
the DNAM-1–associated p95 was Vav-1.
We then evaluated whether other known regulators of 
NK cell activation were tyrosine phosphorylated in response 
to DNAM-1 engagement by immunoprecipitating total cell 
lysates with substrate-specific antibodies, followed by anti-
phosphotyrosine immunoblotting (Fig. 6 C). Engagement of 
WT DNAM-1 triggered tyrosine phosphorylation not only 
of Vav-1, but also of phospholipase (PLC)-γ1, ubiquitin li-
gase c-Cbl, and lipid phosphatase SHIP-1. There was no im-
pact on tyrosine phosphorylation of kinase Syk or adaptor 
SLP-76 (Fig.  6 C; not depicted). These signals were absent 
in cells containing DNAM-1 Y319F or DNAM-1 N312Q. 
Mutation of Y319F also abolished the ability of DNAM-1 to 
increase intracellular calcium, which is a downstream effec-
tor of PLC-γ1 (Fig. 6 D). It should be noted that PLC-γ1, 
c-Cbl, and SHIP-1 were not detectably associated with 
DNAM-1 (unpublished data).
Next, activation of Akt in response to DNAM-1 (Fig. 1) 
raised the possibility that DNAM-1 also stimulated PI3′K, a 
key upstream regulator of Akt. Because the Grb2 SH3 do-
mains can bind to the PI3′K regulatory subunit p85 (Wang 
et al., 1995), we examined whether engagement of DNAM-1 
triggered recruitment of p85 to DNAM-1 (Fig. 6 E). Trig-
gering of WT DNAM-1, but not DNAM-1 Y319F, induced 
coimmunoprecipitation of DNAM-1 with p85. This effect 
was absent in cells lacking DNAM-1.
Finally, to help identify the signals playing key roles 
in DNAM-1–mediated cytotoxicity, YT-S cells expressing 
mouse DNAM-1 were treated with various pharmacological 
inhibitors, and the impact on cytotoxicity toward RMA-S 
cells expressing CD155 was determined (Fig. 6, F and G). This 
system was chosen because killing of the target cell variant 
was strictly dependent on DNAM-1 function in YT-S cells 
(Fig. 1 H). Wortmannin, a PI3′K inhibitor, caused a profound 
suppression of cytotoxicity mediated by DNAM-1 (Fig. 6 F 
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Figure 6. The tyrosine- and asparag-
ine-based motif couples DNAM-1 to mul-
tiple effectors. (A) YT-S cells expressing WT 
or Y319F mouse DNAM-1 were stimulated for 
the indicated times with anti–DNAM-1 and 
the relevant secondary antibody. DNAM-1 was 
then immunoprecipitated from cell lysates, and 
DNAM-1–associated proteins were detected 
by immunoblotting with anti-phosphotyrosine 
antibodies (α-P.tyr). The positions of DNAM-1 
and p95 are indicated on the right. Migration 
of prestained molecular weight markers and 
heavy chain of IgG is shown on the left. It is 
notable that the amount of DNAM-1 recov-
ered from cells expressing WT DNAM-1, but 
not DNAM-1 Y319F, was diminished upon 
anti–DNAM-1 stimulation. This finding likely 
indicated that signaling-competent DNAM-1 
became detergent-insoluble upon stimulation. 
Representative of n = 4. (B) YT-S cells express-
ing the indicated variants of DNAM-1 were 
stimulated for 15  s with anti–DNAM-1 anti-
bodies and the relevant secondary antibody. 
After extensive washing, eluates of DNAM-1 
immunoprecipitates were reimmunoprecipi-
tated with anti-Vav-1 or normal rabbit serum 
(NRS). Tyrosine phosphorylated proteins were 
detected by anti-phosphotyrosine immuno-
blotting. Representative of n = 3. (C) YT-S cells 
expressing the indicated variants of DNAM-1 
or the puromycin resistance marker (puro) 
alone were stimulated with anti–DNAM-1 fol-
lowed by the relevant secondary antibodies. 
Lysates were then immunoprecipitated with 
antibodies against the specified substrates and 
tyrosine phosphorylation was analyzed by im-
munoblotting with α-P.tyr. Quantitation of rel-
ative phosphorylation is shown at the bottom. 
Representative of at least n = 3. (D) YT-S cells 
expressing the indicated variants of DNAM-1 
or the puromycin resistance marker (puro) 
alone were stimulated with anti–DNAM-1 an-
tibodies and the relevant secondary antibody. 
Changes in intracellular calcium were analyzed 
as described for Fig. 1 G. Representative of n = 3. 
(E) YT-S cells expressing the indicated vari-
ants of DNAM-1 or the puromycin resistance 
marker (puro) alone were stimulated for 15 s with anti–DNAM-1 antibodies and the relevant secondary antibody. DNAM-1 was then immunoprecipitated 
and its association with p85 was detected by immunoblotting with anti-p85. Representative of n = 3. (F and G) YT-S cells expressing WT mouse DNAM-1 
were treated with wortmannin (0.1  µM), 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester; BAP TA-AM; 40  µM), 
U0126 (1 µM), ibrutinib (10 nM), or dimethysulfoxide (DMSO) alone as control, and their capacity to kill RMA-S-CD155 cells was assessed in a 51Cr-release 
assay (left). Average values at the 25:1 E/T ratio from 5 independent experiments are shown on the right. Representative of n = 5 (F) or n = 3 (G). SDs of 
duplicate values are depicted by error bars. Unpaired Student’s t tests were performed. n.s., not statistically significant. *, P < 0.05; ***, P < 0.001. (H) Sple-
nocytes from WT mice were stimulated with B16 cells in the presence of the indicated compounds, as detailed for H. Expression of CD107a on DNAM-1+ NK 
cells (NK1.1+CD3−DNAM-1+) was analyzed by flow cytometry. Splenocytes alone or splenocytes stimulated with phorbol myristate acetate and ionomycin 
(PMA/iono) served as controls. Average values with SDs of triplicate values from one representative experiment are depicted. Unpaired Student’s t tests were 
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tetrakis(acetoxymethyl ester; BAP TA-AM), a calcium chela-
tor. However, no impact was observed with U0126, an in-
hibitor of the Erk pathway, or ibrutinib, an inhibitor of the 
kinase Btk (Fig. 6, F and G). These various compounds had 
no deleterious effect on cell viability (unpublished data).
To provide evidence that PI3′K was also involved in 
DNAM-1–dependent degranulation in primary NK cells, we 
tested the effect of two PI3′K inhibitors, wortmannin and 
Ly294002, on the ability of primary mouse NK cells to ex-
pose CD107a, a marker of granule exocytosis, in response to 
B16 melanoma cells (Fig. 6 H). Treatment with either inhibi-
tor resulted in significant inhibition on the increased CD107a 
exposure in response to B16 cells.
As Vav-1, c-Cbl, SHIP-1, and p85 bind the Grb2 SH3 
domains (Ramos-Morales et al., 1994; Odai et al., 1995; 
Kavanaugh et al., 1996), these findings supported that idea 
that Grb2 was responsible for coupling DNAM-1 to these 
effectors. Our data with pharmacological inhibitors also sug-
gested that activation of PI3′K and, to a lesser extent, cal-
cium fluxes (a PLC-γ1 effector) were especially important for 
DNAM-1–dependent cytotoxicity.
Fyn and LFA-1 are not critical for DNAM-1 signaling
Previous studies suggested that Fyn was critical for phos-
phorylation of DNAM-1 at Y319 and, thus, for DNAM-1 
function (Shibuya et al., 1999). To assess if Fyn was needed 
for DNAM-1 signaling, the ability of DNAM-1 to mediate 
signals and enhance cytotoxicity was examined in NK cells 
from Fyn-deficient mice (Fig. 7, A–C). Fyn deficiency had 
no impact on DNAM-1 expression on NK cells (Fig. 7 A). 
More importantly, it had little or no effect on the capacity 
of DNAM-1 to trigger activation of Erk and Akt (Fig. 7 B). 
Nonetheless, as previously reported, loss of Fyn reduced 
the ability of NK cells to kill a broad range of targets 
(Bloch-Queyrat et al., 2005; Dong et al., 2012; Fig.  7  C). 
This effect was seen whether target cells expressed or not 
DNAM-1 ligands. These findings indicated that Fyn was not 
absolutely required for the signaling capacity of DNAM-1. 
However, it was needed for NK cell–mediated cytotoxicity, 
presumably by receptors other than DNAM-1.
It was also proposed that LFA-1 was critical for the ca-
pacity of DNAM-1 to promote NK cell functions (Shibuya 
et al., 1999). To examine if LFA-1 was required for DNAM-1 
signaling, the function of DNAM-1 was examined in NK 
cells from LFA-1–deficient mice (Fig. 7, D–F). Lack of LFA-1 
had no impact on DNAM-1 expression (Fig. 7 D). Surpris-
ingly, it also had no effect on the capacity of DNAM-1 to 
activate Erk and Akt (Fig. 7 E). However, lack of LFA-1 re-
duced the ability of NK cells to kill some, but not all, target 
cells. As was the case for Fyn deficiency, this effect was seen 
whether target cells did or did not express DNAM-1 ligands. 
In particular, an effect was seen on RMA-S, which expressed 
ICAM-1 and ICAM-2, but did not express DNAM-1 ligands 
(Fig. 7 F). In contrast, there was no impact on B16 and CMT-
93, which had little or no ICAM-1 and ICAM-2 (Fig. 7 G), 
but were killed in a DNAM-1–dependent manner (Fig. 4). 
These findings implied that LFA-1 was not strictly needed for 
the signaling capabilities and activating function of DNAM-1.
Next, we determined which classes of PTKs were re-
sponsible for phosphorylation of Y319 of DNAM-1 (Fig. 7, 
H and I). Co-transfection experiments in Cos-1 cells re-
vealed that Src family kinases Fyn and, to a lesser extent, Lyn, 
Src, and Lck, were able to trigger tyrosine phosphorylation 
of DNAM-1 (Fig.  7 H). No phosphorylation was induced 
by Syk and ZAP-70, which belong to a distinct PTK family. 
In the light of these results, we examined the impact of Src 
family kinase inhibitor PP2 on tyrosine phosphorylation of 
DNAM-1 in NK cells (Fig. 7 I). Treatment of YT-S cells with 
PP2 fully prevented the ability of anti–DNAM-1 to induce 
tyrosine phosphorylation of DNAM-1 and the associated 
Vav-1. It also suppressed the ability of anti–DNAM-1 to trig-
ger the association of DNAM-1 with Grb2.
Thus, although Fyn and LFA-1 played a key role 
in activation via a wide range of activating receptors, they 
were not strictly required for DNAM-1 signaling. Further-
more, multiple Src family kinases, including not only Fyn 
but also Lyn, Src, and Lck, were able to trigger DNAM-1 
tyrosine phosphorylation.
DNAM-1 signaling promotes actin polymerization 
and granule polarization
DNAM-1 was shown to serve at least in part as an adhesion 
receptor, which promotes NK cell activation by stabilizing 
conjugate formation between NK cells and target cells, one 
of the key steps of NK cell synapse formation (Shibuya et 
al., 1996; Orange, 2008). To assess if this function required 
DNAM-1 signaling and was sufficient to promote NK cell 
activation, we evaluated the impact of DNAM-1 and its sig-
naling motif on various steps of NK cell–mediated cytotoxic-
ity (Fig. 8). First, conjugate formation between NK cells and 
target cells was analyzed, using YT-S cells expressing various 
forms of mouse DNAM-1 and a flow cytometry–based assay 
(Fig.  8, A–C). WT DNAM-1 markedly enhanced the abil-
ity of NK cells to form stable conjugates with RMA-S cells 
expressing mouse CD155 (Fig. 8 A). Surprisingly, however, 
the signaling-defective DNAM-1 Y319F and N321Q mu-
tants also increased conjugate formation, even though they 
did not promote cytotoxicity. A time-course analysis and a 
quantitation are depicted in Fig. 8 B. The signaling-compe-
tent DNAM-1 S326A mutant behaved like WT DNAM-1 in 
this assay (Fig. 8 C).
This observation implied that the ability of DNAM-1 
to enhance adhesion was not sufficient to promote cytotox-
icity. In this light, we examined the impact of DNAM-1 on 
subsequent events of NK cell activation, in particular actin 
polymerization and polarization of lytic granules, using con-
focal microscopy (Orange, 2008; Fig.  8, D–F). YT-S cells 
expressing WT DNAM-1, DNAM-1 Y319F, DNAM-1 
N321Q, or DNAM-1 S326A were incubated with RMA-S 
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Figure 7. Role of Fyn and LFA-1 in DNAM-1 signaling. (A) Expression of DNAM-1 was analyzed on NK cells (NK1.1+CD3− splenocytes) from WT and 
Fyn-deficient (KO) mice. Isotype control is shown as filled histogram. Representative of n = 4. (B) NK cells from the indicated mice were stimulated 
for 2 min with anti–DNAM-1 antibodies and the relevant secondary antibody. Phosphorylation of Erk and Akt was assessed as detailed for Fig. 1 A. Quanti-
tation of relative phosphorylation is shown at the bottom. Representative of n = 2. (C) Natural cytotoxicity of NK cells toward a variety of targets was tested 
in a 51Cr-release assay at indicated effector-to-target (E/T) ratio. SDs of duplicate values are depicted by error bars. Representative of n = 4. (D–F) Same as 
A–C, except that WT and LFA-1–deficient (KO) mice were analyzed. Representative of n = 3. (G) Expression of LFA-1 ligands on the indicated targets was 
determined by flow cytometry. Red line, isotype control. Representative of n = 2. (H) Mouse DNAM-1 was coexpressed with the indicated protein tyrosine 
kinases (PTKs) in Cos-1 cells. DNAM-1 was then immunoprecipitated and probed by immunoblotting with anti-phosphotyrosine (α-P.tyr) antibodies. Expres-
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They were then stained with fluorescent phalloidin, to de-
tect polymerized actin, and antibodies against perforin and 
tubulin to detect lytic granules and microtubule-organizing 
centers, respectively. Target cells were also distinguished from 
NK cells, by labeling the former with CellTrace violet. Ex-
amples of conjugates in which NK cells displayed polarized 
or nonpolarized granules are depicted in Fig. 8 D.
In keeping with the aforementioned results, conju-
gates between NK cells and target cells were more abundant 
when YT-S cells expressed any of the DNAM-1 variants, 
compared with cells lacking DNAM-1 (unpublished data). 
However, among these conjugates, NK cells expressing WT 
DNAM-1 and DNAM-1 S326A exhibited more frequent 
actin polymerization and polarized granules, in comparison 
to cells expressing the signaling-defective DNAM-1 Y319F 
and N322Q (Fig. 8, E and F).
Primary mouse NK cells are difficult to analyze by con-
focal microscopy. To show that DNAM-1 signaling also en-
hanced granule polarization in mouse NK cells, we evaluated 
externalization of CD107a in NK cells from WT, DNAM-1–
deficient, or DNAM-1 Y319F mice (Fig. 8, G and H). Com-
pared with WT NK cells, NK cells from DNAM-1–deficient 
or DNAM-1 Y319F mice exhibited diminished CD107a ex-
posure in response to B16 targets (Fig. 8 G). No difference 
was seen in response to PMA and ionomycin. Similar results 
were obtained when only DNAM-1+ NK cells from WT and 
DNAM-1 Y319F mice were compared (Fig. 8 H).
Therefore, augmentation of NK cell adhesion by 
DNAM-1 was signaling-independent and insufficient to pro-
mote cytotoxicity. DNAM-1 signaling enhanced NK cell cy-
totoxicity by favoring actin polymerization and lytic granule 
polarization, rather than by enhancing conjugate formation.
DIS CUSSI ON
Herein, we examined whether DNAM-1 mediates intrinsic 
signals and whether these signals are critical for DNAM-1 
to promote NK cell activation. Our initial studies showed 
that engagement of mouse DNAM-1 on NK cells by anti–
DNAM-1 antibodies resulted in activation of Erk, Akt and 
calcium fluxes, three positive regulators of NK cell activa-
tion. This effect was seen in normal mouse NK cells and 
the human NK cell line YT-S. It was strictly dependent on 
DNAM-1 expression on NK cells, implying that it was truly 
mediated by engagement of DNAM-1, rather than by non-
specific triggering of other receptors such as Fc receptors. 
It is possible that the inability to detect these signals in an 
earlier study using a human NK cell line was due to differ-
ences in stimulation protocols or in the NK cell populations 
studied (Chen et al., 2007).
Structure–function analyses provided strong evidence 
that DNAM-1–mediated signals were crucial for the capac-
ity to promote NK cell activation. In particular, mutation of 
Y319, a site of tyrosine phosphorylation in the cytoplasmic 
domain of DNAM-1, completely abrogated the ability of 
DNAM-1 to signal and promote cytotoxicity in YT-S cells. 
Interestingly, similar effects were seen when an asparagine lo-
cated at the +2 position vis-à-vis Y319, N321, was mutated. 
In contrast, no effect was seen when a less conserved site of 
phosphorylation, S326, was mutated. Thus, the tyrosine- and 
asparagine-containing motif, but not S326, was necessary for 
the ability of DNAM-1 to signal and promote NK cell activa-
tion. Both Y319 and N321 are highly conserved across species.
Introduction of the DNAM-1 Y319F mutation in the 
mouse germline also dramatically reduced the capacity of 
DNAM-1 to trigger signals, natural cytotoxicity, and cytokine 
production in mouse NK cells. This observation validated the 
findings made in YT-S cells. It should be mentioned, how-
ever, that the Y319F mutation did not completely eliminate 
all functions of DNAM-1 in mouse NK cells. A small resid-
ual activity seemingly remained. In comparison to NK cells 
lacking DNAM-1, cells expressing DNAM-1 Y319F had a 
slightly less compromised ability to mediate cytotoxicity to-
ward B16 and Neuro-2a. Furthermore, DNAM-1 Y319F was 
capable of triggering a small degree of calcium flux, although 
this response was much weaker than that evoked by WT 
DNAM-1. Thus, in mouse NK cells, the Y319F mutant was 
capable of mediating some signals, albeit much more weakly 
than WT DNAM-1. It is possible that this residual activity re-
lated to the existence of an additional minor signaling motif, 
which might be active in mouse NK cells but not in YT-S 
cells. Future studies will be needed to address this possibility.
The molecular mechanism by which the tyrosine- 
and asparagine-containing motif triggered signals was next 
characterized. Immunoprecipitation experiments in YT-S 
cells showed that engagement of DNAM-1 triggered ty-
rosine phosphorylation of DNAM-1. This phosphoryla-
tion was abolished when Y319 was mutated, implying that 
it occurred at Y319. Engagement of DNAM-1 also in-
duced tyrosine phosphorylation of Vav-1, PLC-γ1, c-Cbl, 
and SHIP-1. All these events were eliminated when either 
Y319 or N321 was mutated.
Several lines of evidence indicated that the tyrosine- 
and asparagine-based motif was promoting NK cell activa-
tion by linking DNAM-1 to Grb2. First, the tyrosine- and 
asparagine-based motif is a typical consensus binding se-
quence for the Grb2 SH2 domain (pYxNx; Songyang et al., 
1994). Second, Grb2 was the sole polypeptide recovered with 
a peptide encompassing phosphorylated Y319 and N321 of 
mouse DNAM-1 were stimulated for 15 s with anti–DNAM-1 and the relevant secondary antibodies, in the absence or in the presence of the indicated 
concentrations of the Src family kinase inhibitor, PP2. DNAM-1 then was recovered from cell lysates by immunoprecipitation and probed by immunoblotting 
with anti-phosphotyrosine (α-P.tyr) or anti-Grb2 antibodies. Treatment with DMSO alone served as control (Ctr). The migration of molecular mass markers 
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Figure 8. Impact of DNAM-1 signaling on conjugate formation, actin polymerization, and granule polarization. (A–C) The indicated derivatives 
of YT-S cells (labeled with Brilliant Violet 421-conjugated anti–human NKp46) were incubated with RMA-S-GFP or RMA-S-CD155 (labeled with Alexa Fluor 
647–conjugated anti–mouse SLAM). Formation of conjugates (identified as NKp46+SLAM+) at the indicated times was examined by flow cytometry. A repre-
sentative experiment is shown in A. The percentages of conjugates formed are indicated at the top. Statistical analysis of one representative experiment with 
SD of duplicate values is shown in B and C. Representative of at least n = 3. (D–F) Derivatives of YT-S cells and CellTrace violet-loaded RMA-S-CD155 cells 
were incubated for 30 min, loaded on poly-L-lysine–coated slides, and stained with phalloidin, anti-perforin, and anti-tubulin. Conjugates were analyzed 
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DNAM-1 in pull-down assays. Third, mutation of Y319 or 
N321 eliminated the ability of DNAM-1 to bind Grb2 and, 
in parallel, abolished its capacity to signal and enhance cy-
totoxicity in a system in which cytotoxicity was strictly de-
pendent on DNAM-1. Fourth, depletion of Grb2 using two 
different siRNAs reduced the ability of DNAM-1 to mediate 
killing by YT-S cells, once again in a setting where killing 
was absolutely DNAM-1 dependent. Fifth, other effectors of 
DNAM-1 signaling, namely Vav-1, c-Cbl, SHIP-1, and p85 
of PI3′K are known to bind the SH3 domains of Grb2 
(Ramos-Morales et al., 1994; Odai et al., 1995; Wang et al., 
1995; Kavanaugh et al., 1996).
Although the role of these various effectors in DNAM-1–
mediated signals and cytotoxicity remains to be clarified, we 
speculate that Vav-1, PI3′K, and PLC-γ1 were likely respon-
sible for DNAM-1–elicited activation of Erk, Akt, and cal-
cium fluxes, as well as for induction of effector functions. Our 
experiments with pharmacological inhibitors suggested that 
PI3′K and, to a lesser extent, calcium fluxes were especially 
important for induction of cytotoxicity. Conversely, c-Cbl 
and SHIP-1 might be part of a negative feedback mechanism 
aimed at restricting the activating impact of DNAM-1.
Early studies showed that human DNAM-1 promoted 
adhesion between NK cells and target cells (Shibuya et al., 
1996). This finding was confirmed in the present study using 
mouse DNAM-1. However, we also observed that, although 
the signal-defective DNAM-1 mutants Y319F and N321Q 
promoted conjugate formation, they failed to enhance cytotox-
icity. This observation implied that enhanced adhesion was not 
sufficient for the activating function of DNAM-1. Along these 
lines, confocal microscopy studies in YT-S cells showed that WT 
DNAM-1 was also able to augment actin polymerization and 
polarization of lytic granules toward target cells. Importantly, 
these effects were absent with the signal-defective Y319F and 
N321Q DNAM-1 variants. The ability of DNAM-1 to pro-
mote granule exocytosis was also eliminated when the Y319F 
mutation was introduced in mouse NK cells. On these bases, we 
propose that DNAM-1–induced adhesion is likely to be im-
portant, but is not sufficient, for enhancing NK cell activation. 
In addition, the ability of DNAM-1, at least mouse DNAM-1, to 
stimulate actin polymerization and granule polarization, which 
require DNAM-1 signaling, is required. Although it remains to 
be established that an analogous mechanism exists for human 
DNAM-1, it seems likely to be the case as the signaling motif of 
DNAM-1 is strictly conserved in human DNAM-1.
Fyn and LFA-1 were previously suggested to play 
key roles in the function of human DNAM-1 (Shibuya et 
al., 1999). However, using NK cells from Fyn-deficient or 
LFA-1–deficient mice, we observed that Fyn and LFA-1 
were not strictly needed for DNAM-1 signaling. Nonethe-
less, as reported, both were necessary for NK cell activation 
in response to various targets, whether targets did or did 
not express ligands for DNAM-1 (Matsumoto et al., 1998; 
Bloch-Queyrat et al., 2005; Dong et al., 2012). This finding 
implied that Fyn and LFA-1 were needed for the function 
of activating receptors other than DNAM-1. Based on trans-
fection assays in Cos-1 cells, it is probable that, in addition 
to Fyn, other members of the Src family, such as Lyn, Src, 
and Lck, participated in DNAM-1 signaling, at least in the 
mouse. Likewise, it is likely that, in addition to LFA-1, other 
integrins were implicated in DNAM-1–dependent killing. 
This is especially true for targets such as B16 and CMT-93, 
which were killed in a DNAM-1–dependent manner but 
lacked ligands for LFA-1.
Although our data showed that the highly conserved 
Y319, but not the less conserved S326, was needed for the 
capacity of mouse DNAM-1 to mediate signals and pro-
mote NK cell cytotoxicity, Nabekura et al. (2014) recently 
showed that both Y319 and S326 were critical for mouse 
DNAM-1–dependent accumulation of memory NK cells in 
MCMV-infected mice. One possible explanation for these 
divergent results is that signals emanating from S326 are not 
needed for natural cytotoxicity, but are required for expansion 
of memory-like NK cells. It is also plausible that these differ-
ent findings reflected distinctions in experimental conditions 
or systems. We mutated S326 to alanine (a conserved substi-
tution) and tested the function of this mutant in the human 
YT-S cell line. Alternatively, Nabekura et al. (2014) replaced 
S326 by phenylalanine and studied the activity of this mutant 
in a competitive assay using bone marrow–reconstituted mice.
Although DNAM-1 may be strictly speaking the sole 
member of its family, other activating and co-stimulatory 
receptors use Grb2 as their immediate effector, by way of 
a sequence christened immunoglobulin tyrosine tail (ITT) 
motif (Engels et al., 2009; Engels and Wienands, 2011). These 
ITT motif-containing receptors include NKG2D, CD28, 
and membrane-bound IgG. Whereas DNAM-1 interacted 
with Grb2 by way of the sequence pYVNY (critical resi-
dues are underlined; this study), NKG2D interacts with Grb2 
via the motif pYINM found in the NKG2D-associated 
are shown in D. Bars, 10 µm. Percentages of conjugates in which YT-S cells displayed polymerized actin near the synapse or polarized granules are shown 
in E and F. For each YT-S derivative, >100 conjugates were analyzed. Averages of four values for each cell type pooled from two independent experiments 
are depicted in E and F. SDs are shown by error bars. Unpaired Student’s t tests were performed. n.s., non significant. **, P < 0.01; ***, P < 0.001. (G and H) 
Splenocytes from the indicated poly(I:C)-primed mice were incubated for 6 h with B16 cells. Expression of CD107a on NK cells (NK1.1+CD3−; G) or DNAM-
1+ NK cells (NK1.1+CD3−DNAM-1+; H) was analyzed by flow cytometry. Splenocytes alone or splenocytes stimulated with phorbol myristate acetate and 
ionomycin (PMA/iono) served as controls. Representative dot plots are shown in (G, left). Percentages of CD107a-positive NK cells are shown above the 
blue boxes. Average values with SDs of triplicate values from one representative experiment are depicted in G (right; H). Unpaired Student’s t tests were 
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adaptor DAP-10 (Engels and Wienands, 2011). Conversely, 
CD28 interacts with Grb2 through the sequence pYMNM, 
whereas membrane-bound IgG binds Grb2 via the sequence 
pYRNM. In this manner, DNAM-1 is analogous to ITT mo-
tif-bearing receptors. However, in the case of NKG2D, CD28, 
and surface IgG, the ITT motif also directly interacts with the 
p85 subunit of PI3′K. This interaction is dependent on the 
methionine at the +3 position of their ITT motif. Although 
DNAM-1 does not carry a methionine at the +3 position, it 
also coupled to PI3′K, seemingly by an indirect mechanism 
involving binding of Grb2 to p85. Thus, it would appear that 
DNAM-1 also signals via an ITT-like motif.
One of the concerns in elucidating the functions of 
DNAM-1 using DNAM-1–deficient mice is that loss of 
DNAM-1 not only obliterates DNAM-1–dependent signals, 
but also frees DNAM-1 ligands for potential binding to in-
hibitory receptors TIG IT and CD96 (Martinet and Smyth, 
2015). Thus, enhanced triggering of TIG IT and CD96, 
rather than loss of DNAM-1–dependent signals, might ex-
plain functional changes in DNAM-1–deficient immune 
cells. Our finding that mutation of Y319 of DNAM-1 mark-
edly reduced DNAM-1–dependent cytotoxicity and cyto-
kine production in mouse NK cells, without compromising 
DNAM-1 expression, firmly established that these functions 
are intrinsic activities of DNAM-1. Given the functional in-
terplay between DNAM-1, CD96, and TIG IT in anti-tumor 
immunity in vivo, it will be interesting in the future to ex-
amine if tumor rejection and mouse survival differs between 
animals lacking DNAM-1 (in which DNAM-1 function is 
ablated, and DNAM-1 ligands are more available for CD96 
and TIG IT) and mice expressing DNAM-1 Y319F (in which 
DNAM-1 signaling is compromised, but DNAM-1 ligands 
are presumably not more available for CD96 and TIG IT).
In summary, our results showed that DNAM-1 mediates 
active biochemical signals that are essential for its capacity 
to enhance NK cell cytotoxicity and cytokine production. 
These signals are initiated by a conserved ITT or ITT-like 
motif (pYxNx), which undergoes phosphorylation by Src 
family kinases and recruits the adaptor Grb2. In turn, Grb2 
activates Vav-1, PI3′K, and PLC-γ1, which leads to activa-
tion of Erk, Akt, and calcium fluxes. Such a pathway pro-
motes actin polymerization and granule polarization, thereby 
enhancing cytotoxicity. As DNAM-1 is expressed in other 
immune cells, including CD8+ T cells, it is reasonable to spec-
ulate that DNAM-1 mediates similar signals and effects in 
these cells. Likewise, it is likely that an enhancement of these 
signals, due to augmented triggering of DNAM-1 by its li-
gands, underlies the therapeutic impact of blocking anti-TIG 
IT antibodies for treatment of cancer and viral infections 
(Johnston et al., 2014).
MAT ERIALS AND MET HODS
Mice. To generate a mouse strain in which Y319 of DNAM-1 
was substituted by phenylalanine, the targeting vector de-
picted in Fig.  3  A was created. This construct contained a 
5-kb 3′ arm harboring exon 7, in which the codon for Y319 
(TAT) was replaced by the codon for phenylalanine (TTT). 
The construct was transfected in C57BL/6-derived Bruce 4 
ES cells. Cells with successful homologous recombination 
were injected into blastocysts to generate chimeric mice. 
After germline transmission, mice were crossed with a trans-
genic mouse expressing the Flpe recombinase [B6.SJL-
Tg(ACT FLPe)9205Dym/J; The Jackson Laboratory] to 
eliminate the neo cassette. Presence of the DNAM-1 Y319F 
mutation was confirmed by sequencing of mouse genomic 
DNA. DNAM-1–deficient mice in the C57BL/6 back-
ground were previously described (Gilfillan et al., 2008). 
LFA-1–deficient mice (B6.129S7-Itgaltm1Bll/J) were obtained 
from The Jackson Laboratory (Ding et al., 1999). Mice lack-
ing Fyn were described previously (Dong et al., 2012). All 
mice were maintained in the C57BL/6 background. Litter-
mates were used as controls in all experiments. Animal exper-
imentation was approved by the Animal Care Committee 
of IRCM and performed as defined by the Canadian 
Council of Animal Care.
cDNAs, plasmids, and siRNAs. cDNAs encoding mouse 
DNAM-1 and CD155 were obtained from Thermo Fisher 
Scientific. Mutants of DNAM-1 (Y319F; S326A; N321Q; 
Y322F) were generated by PCR using the Site-Directed 
Mutagenesis Kit (QuickChange; Agilent Technologies), ac-
cording to the instructions of the manufacturer. The resulting 
cDNAs were verified by sequencing (unpublished data). For 
expression in YT-S cells, cDNAs coding for DNAM-1 were 
cloned into the vector pSRα-Puro, which contains the puro-
mycin resistance gene (puro). For expression in Cos-1 cells, 
cDNAs encoding DNAM-1 or various PTKs were cloned in 
the vector pXM139. For expression of CD155 in RMA-S 
cells, the cDNA encoding CD155 was cloned into the retro-
viral vector pFB-GFP. Grb2-specific siRNAs (SI00300328, 
SI02654750) and control scrambled siRNAs (1027280) were 
obtained from QIA GEN. Transfection of siRNAs into YT-S 
cells was performed as described elsewhere (Guo et al., 2015).
Cells. To obtain freshly isolated NK cells, mice were injected 
intraperitoneally with poly(I:C; 250 µg; Sigma-Aldrich). After 
36 h, spleen NK cells were purified by positive selection (STE 
MCELL Technologies). For generation of IL-2–activated NK 
cells, spleen NK cells were enriched by negative selection 
(STE MCELL Technologies) and cultured for 5 d in the pres-
ence of 1,000 U/ml of mouse IL-2 (PeproTech). YT-S (human 
NK cell line), B16F10 (mouse melanoma), CMT-93 (mouse 
rectal carcinoma), RMA-S (mouse lymphoma), and YAC-1 
(mouse thymoma) were described (Dong et al., 2009; 
Pérez-Quintero et al., 2014). Neuro-2a (neuroblastoma) was 
a gift from N. Seidah (Institut de recherches cliniques de 
Montréal, Montreal, Quebec, Canada). YT-S cells expressing 
various mutants of mouse DNAM-1 were generated by elec-
troporation and selected in puromycin-containing medium. 
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alone or in combination with mouse CD155 were produced 
by retroviral infection, as detailed previously (Cruz-Munoz et 
al., 2009). Cos-1 (monkey kidney fibroblast) and its transfec-
tion were outlined previously (Guo et al., 2015).
Antibodies. A monoclonal antibody against mouse DNAM-1 
(480.2) was previously described (Gilfillan et al., 2008). Poly-
clonal antibodies against mouse DNAM-1 were generated by 
immunizing rabbits with the mouse DNAM-1 cytoplasmic 
domain fused to glutathione-S-transferase (GST). Antibodies 
against Vav-1, SHIP-1, c-Cbl, Fyn, Lyn, Src, Lck, Syk, and 
ZAP-70 were produced in our laboratory. Monoclonal anti-
bodies recognizing DNAM-1 (10E5), CD155 (TX56), CD3 
(145-2C11), NK1.1 (PK136), CD11b (M1/70), CD27 (LG 
7F9), IFN-γ (XMG1.2), CD107a (1D4B), Ly49A/D (11A8), 
Ly49G2 (LGL-1), Ly49C/I/F/H (14B11), CD122 (TMb1), 
NKG2D (CX5), CD11a (M17/4), 2B4 (244F4), CD49b 
(DX5), NKp46 and ICAM-1 (CD54; YN1/1.7.4), and 
matched isotype controls, were obtained from eBioscience. 
Antibodies against CD112 (MAB3387) were purchased from 
Abnova. Antibodies against ICAM-2 (CD102; 3C4), human 
NKp46 (9E2), and perforin (dG9) were obtained from Bio-
Legend. NKG2D-Fc was obtained from R&D Systems. Poly-
clonal rabbit anti–rat IgG and goat anti–rat IgG antibodies 
were purchased from Jackson ImmunoResearch Laboratories. 
Antibodies against phosphorylated Erk (E10), p44/p42 
MAPK (9102), phosphorylated Akt (9271), and Akt (9272) 
were obtained from Cell Signaling Technology. Antibodies to 
β-actin (C4), Grb2 (C-23), and PLC-γ1 (sc-81) were pur-
chased from Santa Cruz Biotechnology, Inc. Antibodies 
against GST (AB3282), p85 (06–497), and phosphotyrosine 
(4G10) were from Millipore. Anti-tubulin (236–10501) and 
phalloidin (A22283) were purchased from Life Technologies. 
Antibodies against mouse SLAM (12F12) were pro-
duced in our laboratory.
In vitro NK cell assays. 51Cr release assays were performed as 
outlined previously, using either YT-S cells or IL-2–activated 
NK cells (Dong et al., 2009). For measurement of IFN-γ pro-
duction and CD107a exposure, splenocytes (1 × 106) from 
poly(I:C)-primed mice were incubated for 6 h with B16 cells 
(1 × 105), and assays were performed as previously described 
(Dong et al., 2009). Splenocytes stimulated with phorbol 
myristate acetate (50 ng/ml) plus ionomycin (1 µM) served as 
controls. For inhibition of PI3′K and the upstream activator 
of Erk, MEK, YT-S cells, or splenocytes were preincubated for 
1  h with 0.1  µM wortmannin (EMD Millipore) or 1  µM 
U0126 (Sigma-Aldrich), respectively. For inhibition of cal-
cium fluxes, YT-S cells were preincubated for 0.5  h with 
40 µM BAP TA-AM (Sigma-Aldrich). For inhibition of Btk, 
YT-S cells were preincubated for 0.5 h with 10 nM ibrutinib 
(Sigma-Aldrich). For immunoblot analyses, YT-S cells or 
IL-2–activated mouse NK cells were incubated with anti–
mouse DNAM-1 (480.2) for 10 min at room temperature. 
After being washed, cells were stimulated with the relevant 
secondary antibody at 37°C for the indicated time. Immuno-
precipitations, reimmunoprecipitations, and immunoblots 
were performed as previously described (Yu et al., 2001; 
Dong et al., 2012). To study calcium fluxes in mouse NK cells, 
IL-2–activated NK cells were labeled with FITC-conjugated 
anti–DNAM-1 (10E5) and loaded with Indo-1 (Invitrogen) 
for 20 min at 37°C. After being washed, cells were loaded on 
a BD LSR cell analyzer and the relevant secondary antibody 
was added after 30  s. DNAM-1+ NK cells were gated and 
changes in intracellular calcium over time were measured as 
the Fluo-4 (FL4) to Fluo-5 (FL5) ratio. Cells without addi-
tion of secondary antibody or stimulated with ionomycin 
(0.2 µM) were used as control. Calcium fluxes in YT-S cells 
were measured in a similar way, except that YT-S cells were 
stimulated by anti–mouse DNAM-1 (480.2), followed by the 
relevant secondary antibody. Cells treated with only the sec-
ondary antibody served as control. Conjugate formation assay 
and confocal microscopy were previously described (Dong et 
al., 2009; Pérez-Quintero et al., 2014).
Peptide pull-down assay, silver staining, and mass spectrom-
etry. Biotinylated peptides encompassing the 19 aa C-terminal 
sequence of mouse DNAM-1, phosphorylated or not at 
Y319, were synthesized by the W.M. Keck Facility (Yale Uni-
versity). Variants of this peptide in which individual residues 
were mutated were also created. Peptide pull-down assay was 
performed as described previously (Dong et al., 2009; 
Pérez-Quintero et al., 2014). Silver staining and mass spec-
trometry were performed at the Proteomic Mass Spec-
trometry Platform of IRCM.
Statistical analyses. Prism 6 (GraphPad Software) was used 
for unpaired Student’s t tests (two-tailed).
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